Jointown Pharmaceutical Group
Overview
Jointown Pharmaceutical Group Co., Ltd. is a technology-driven comprehensive service provider for the whole chain pharmaceutical industry, based on the comprehensive health industry. Its main business comprises digital pharmaceutical distribution and supply chain, general agency brand promotion, pharmaceutical industrial self-production and OEM, new retail and Ten-Thousand Store Alliance Plan, medical health and technology value-added services, and digital logistics technology and supply chain solutions. It is the largest medical company in China that is not state-owned and the 4th largest overall.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Singlera Genomics Inc. | Mar 2018 | Series A Extension | Co-investor |
| Opteran | Nov 2020 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Jointown Pharmaceutical Group based?
Jointown Pharmaceutical Group is headquartered in China.
When was Jointown Pharmaceutical Group founded?
Jointown Pharmaceutical Group was founded in 1985.
How many portfolio companies does Jointown Pharmaceutical Group have?
Jointown Pharmaceutical Group has 2 portfolio companies in Caplight's dataset.
What are some companies in Jointown Pharmaceutical Group's portfolio?
Portfolio companies visible on Caplight include Singlera Genomics Inc., Opteran.
What was Jointown Pharmaceutical Group's most recent investment shown here?
Jointown Pharmaceutical Group's most recent investment in this portfolio sample was in Opteran in 2020.
What sectors does Jointown Pharmaceutical Group focus on?
Jointown Pharmaceutical Group focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Mobility, Transportation & Logistics.
What company stages does Jointown Pharmaceutical Group focus on?
Jointown Pharmaceutical Group typically invests at the Early stage.
What is Jointown Pharmaceutical Group's AUM?
Jointown Pharmaceutical Group's assets under management are estimated between $1.0B and $10.0B.